Cita APA (7a ed.)

AJ, Y., & NS, R. (2012). Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients. Dove Medical Press.

Cita Chicago Style (17a ed.)

AJ, Yee, y Raje NS. Denosumab, a RANK Ligand Inhibitor, for the Management of Bone Loss in Cancer Patients. Dove Medical Press, 2012.

Cita MLA (8a ed.)

AJ, Yee, y Raje NS. Denosumab, a RANK Ligand Inhibitor, for the Management of Bone Loss in Cancer Patients. Dove Medical Press, 2012.